Delayed-Enhancement Cardiovascular Magnetic Resonance in Patients With Sarcoidosis

Part of paid clinical trials in Durham, North Carolina.

Sponsor
Duke University
Study ID
NCT01745237
Status
Recruiting
Apply to this trial

Conditions

  • Sarcoidosis

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The primary objective of this study was to determine the ability of cardiac magnetic resonance (CMR) to identify cardiac involvement in patients with sarcoidosis. Patients were to undergo CMR in addition to routine clinical evaluation.

Key Dates

Start date
Sep 30, 2002
Status verified
Apr 2025
Primary completion
Jun 30, 2032
Completion
Jun 30, 2032

Study Design

Enrollment
27,000 participants (estimated)

Primary Outcome Measure

cardiac mortality [ Time Frame: > 1year ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Duke University Medical CenterDurhamNorth Carolina27707
Han W Kim, MD
[email protected]
919-668-3539
Raymond J Kim, MD
[email protected]
919-668-3539
Raymond J Kim, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Durham, NC

By research site
Duke University Medical Center· Durham, NC

Related Studies